Craft

G&E Herbal

Stock Price

NT$58.3

2024-10-29

Market Capitalization

NT$3.4 B

2024-10-29

Revenue

NT$309.1 M

FY, 2025

G&E Herbal Summary

Company Summary

Overview
G&E Herbal (德英生物科技股份有限司) biopharmaceutical company that manufactures and distributes health care products. It offers dietary supplements, conventional drugs, cosmetics, capsules, and other products.
Type
Public
Status
Active
Founded
2002
Website
https://www.geherbs.com
Sectors

Table of Contents

G&E Herbal Financials

Summary Financials

Revenue (FY, 2025)
NT$309.1M
Gross profit (FY, 2025)
NT$272.2M
Net income (FY, 2025)
NT$139.2M
Cash (FY, 2025)
NT$78.4M
EBIT (FY, 2025)
NT$152.3M
Enterprise value
$3.3B

Footer menu